FRESNO, Calif. (KFSN) -- As artificial intelligence evolves, we're seeing a number of industries use AI to their advantage.
Now, pharmaceutical companies are leaning into the technology to speed the process of drug discovery.
Dotmatics Vice President Phil Mounteney joined us to discuss what this means for consumers.